As aforementioned, results from PD cohorts illustrated in Table 3 shows that lower IGF-1 levels at the beginning of the disease are associated with a worse progression and prognosis, being IGF-1 concentrations higher in PD cohorts at the symptom’s onset. Here, IGF1 is linked to Parkinson disease.